Natalizumab effects on immune cell responses in multiple sclerosis-Reference-Cited by-同舟云学术

Natalizumab effects on immune cell responses in multiple sclerosis

Published:2006-05 Issue:5 Volume:59 Page:748-754
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Niino Masaaki,Bodner Caroline,Simard Marie-Lune,Alatab Sudabeh,Gano Dawn,Kim Ho Jin,Trigueiro Manuela,Racicot Denise,GuÃ©rette Christine,Antel Jack P.,Fournier Alyson,Grand'Maison Francois,Bar-Or Amit

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference26 articles.

1. A controlled trial of natalizumab for relapsing multiple sclerosis;Miller;N Engl J Med,2003

2. Available at: U.S. Food and Drug Administration. FDA News. http://www.fda.gov/bbs/topics/news/2004/NEW01141.html. Accessed Nov 23, 2004.

3. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab;Langer-Gould;N Engl J Med,2005

4. Progressive multifocal lekoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis;Kleinschmidt-Demasters;N Engl J Med,2005

5. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin;Yednock;Nature,1992

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination;Frontiers in Immunology;2024-07-15

2. Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentration;Multiple Sclerosis and Related Disorders;2024-07

3. Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies;Neurologic Clinics;2024-02

4. Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple Sclerosis;Neurology Neuroimmunology & Neuroinflammation;2023-07

5. Recurrent skin infections associated with natalizumab treatment;Neurological Sciences;2022-11-04